<DOC>
	<DOCNO>NCT02896569</DOCNO>
	<brief_summary>The purpose study compare tolerability application combination serum contain human bone marrow stem cell derive growth factor ( SCR Complex ) cytokines botanical lipid-based occlusive ( Bio Cel ) immediately follow fractional radiofrequency treatment use Venus Viva versus standard care .</brief_summary>
	<brief_title>Tolerability Using Post-Treatment Topical Adjuvant Combination Following Fractional Radiofrequency Ablation</brief_title>
	<detailed_description>Randomized , open-label , multi-centre study evaluate tolerability application combination serum contain human bone marrow stem cell derive growth factor cytokine ( SCR Complex™ ) botanical lipid base occlusive ( Bio Cel™ ) follow facial fractional RF treatment use Venus Viva™ SR system . Each subject receive 2 treatment separate 3-week interval . Subjects complete VAS Tolerability Scale immediately follow treatment . Telephone follow-up call site ask subject respond Self-Report Adverse Event Questionnaire 24 72 hour first treatment 24 hour second treatment . Subjects complete Home Tolerability Scale 24 72 hour first treatment 24 hour second treatment . Subjects return final FU visit ask respond Self-Report Adverse Event Questionnaire complete Home Tolerability Scale 72 hour . The investigator also evaluate subject 's improvement use GAIS visit .</detailed_description>
	<mesh_term>Skin Diseases</mesh_term>
	<criteria>Undergoing dermatological procedure require ablation resurface facial skin utilize Venus Viva™ SR system . Women childbearing age require use reliable method birth control prior enrollment throughout participation study . Able tolerate treatment determine test spot application ( ) . Superficial metal implant treatment area Tattoos , permanent makeup , scar piercings treatment area . Any active condition treatment area , sore , psoriasis , eczema rash . Any surgical procedure treatment area within last three month complete healing . Receiving therapy medication may interfere study treatment .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>resurface</keyword>
	<keyword>ablation</keyword>
</DOC>